Computational imaging analysis of fibrin matrices with the inclusion of erythrocytes from homozygous SS blood reveals agglomerated and amorphous structures.
Sickle cell disease is a single point mutation disease that is known to alter the coagulation system, leading to hypercoagulable plasma conditions. These hypercoagulable conditions can lead to complications in the vasculature, caused by fibrin clots that form undesirably. There is a need to understand the morphology and structure of fibrin clots from patients with sickle cell disease, as this could lead to further discovery of treatments and life-saving therapies. In this work, a computational imaging analysis method is presented to evaluate fibrin agglomeration in the presence of erythrocytes (RBCs) homozygous for the sickle cell mutation (SS). Numerical algorithms were used to determine agglomeration of fibrin fibers within a matrix with SS RBCs to test the hypothesis that fibrin matrices with the inclusion of SS RBCs possess a more agglomerated structure than native fibrin matrices with AA RBCs. The numerical results showed that fibrin structures with SS RBCs displayed an overall higher degree of agglomeration as compared to native fibrin structures. The computational algorithm was also used to evaluate fibrin fiber overlap (aggregation) and anisotropy (orientation) in normal fibrin matrices compared to fibrin matrices polymerized around SS RBCs; however, there was no statistical difference. Ultrasound measurements of stiffness revealed rigid RBCs in the case of samples derived from homozygous SS blood, and densely evolving matrices, when compared to normal fibrin with the inclusion of AA RBCs. An agglomeration model is suggested to quantify the fibrin aggregation/clustering near RBCs for both normal fibrin matrices and for the altered structures. The results of this work are important in the sense that the understanding of aggregation and morphology in fibrin clots with incorporation of RBCs from persons living with sickle cell anemia may elucidate the complexities of comorbidities and other disease complications.
Driftmier Engineering Center, College of Engineering, The University of Georgia, 597 D.W. Brooks Drive, Athens, GA, 30602, USA. raverett@uga.edu.
Rodney D
RD
Averett
School of Medicine, Mercer University, 4700 Waters Avenue, Savannah, GA, 31404, USA.|Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, 950 Atlantic Dr., Atlanta, GA, 30332, USA.
David G
DG
Norton
Department of Biomedical Engineering, The University of Texas at San Antonio, 102 One UTSA Circle, San Antonio, TX, 78249, USA.|Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, 950 Atlantic Dr., Atlanta, GA, 30332, USA.
Natalie K
NK
Fan
Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, 950 Atlantic Dr., Atlanta, GA, 30332, USA.
Manu O
MO
Platt
D000465:Algorithms; D000755:Anemia, Sickle Cell / Q000097:blood* / Q000235:genetics; D004903:Erythrocyte Aggregation / Q000235:genetics; D004912:Erythrocytes / Q000378:metabolism*; D005337:Fibrin / Q000378:metabolism / Q000648:ultrastructure*; D006720:Homozygote; D006801:Humans; D021621:Imaging, Three-Dimensional / Q000379:methods*; D018613:Microscopy, Confocal / Q000379:methods*; D066329:Protein Aggregates
D066329:Protein Aggregates; D005337:Fibrin
Aggregation; Algorithm; Confocal microscopy; Fibrin; Sickle cell disease
Annu Rev Biochem. 1984;53:195-229
6383194
Biochem Biophys Res Commun. 2012 May 4;421(2):335-42
22507986
Am J Med. 2003 Dec 15;115(9):721-8
14693325
Biophys J. 2008 Dec 15;95(12):6072-80
18835899
Acta Biomater. 2012 Nov;8(11):4031-42
22828381
J Neurol Sci. 2012 Feb 15;313(1-2):86-91
21992814
Neuroimaging Clin N Am. 2013 Nov;23 (4):781-98
24156865
Thromb Res. 2012 Aug;130(2):259-64
22079446
Blood Rev. 2016 Jul;30(4):245-56
26776344
J Diabetes Complications. 1994 Oct-Dec;8(4):231-4
7833499
Biophys J. 1995 Apr;68(4):1551-60
7787040
Biophys J. 1992 Sep;63(3):774-83
1420913
J Biomech. 2011 Feb 24;44(4):657-61
21111421
Pediatr Pathol Mol Med. 2001 Jan-Feb;20(1):27-46
12673843
Biochim Biophys Acta. 1989 Jul 27;997(1-2):96-110
2752057
Hematol Oncol Clin North Am. 2014 Apr;28(2):355-74
24589271
J Vis Exp. 2015 Apr 01;(98):e52019
25867016
Thromb Res. 2014 May;133(5):880-5
24582462
Thromb Res. 1987 Nov 1;48(3):279-89
3124289
Thromb Res. 2010 Jul;126(1):e11-6
20471669
Acta Biomater. 2014 Apr;10(4):1502-14
24056097
Science. 2009 Aug 7;325(5941):741-4
19661428
Haematologica. 2015 Apr;100(4):466-71
25596272
Biomaterials. 2010 Mar;31(7):1944-54
19914710
Biophys Chem. 2004 Dec 20;112(2-3):267-76
15572258
Blood Cells Mol Dis. 2006 Mar-Apr;36(2):191-3
16488165
J Acoust Soc Am. 1982 Nov;72(5):1364-7
7175019
Biochimie. 2016 Mar;122:314-23
26458976
Blood Cells Mol Dis. 2009 Jan-Feb;42(1):51-6
19054699
Biophys J. 2013 Mar 5;104(5):1151-9
23473498
Thromb Res. 1991 Nov 15;64(4):477-85
1788832
Atherosclerosis. 2013 Aug;229(2):496-503
23746538
Eur J Cardiothorac Surg. 2000 May;17(5):587-91
10814924
Lancet. 1972 Apr 29;1(7757):934-7
4112100
Adv Protein Chem. 2005;70:247-99
15837518
Acta Biomater. 2007 Jan;3(1):59-67
17085089
Biomaterials. 2011 Nov;32(31):7856-69
21816465
Anemia. 2012;2012:201781
22550569
J Biol Chem. 1979 Nov 25;254(22):11272-81
500644
Thromb Res. 1990 Apr 1;58(1):23-33
2343442
Diabetes Metab. 2012 Nov;38(5):462-5
22579719
Biophys J. 2013 Mar 5;104(5):1160-9
23473499
J Stroke Cerebrovasc Dis. 2014 Nov-Dec;23(10):e453-5
25238921